在欧洲的临床实践中使用基于多拉维林的疗法
Agathe Rami1, Anton L Pozniak2,3, Lambert Assoumou4
1Hôpital Saint Louis- Lariboisière, and University of Paris Cité, Paris, France.
AIDS (London, England)
|February 13, 2025
概括
基于多拉维林 (DOR) 的疗法在艾滋病毒感染者 (PWH) 中表现出高的抗病毒有效性和安全性. 这些发现支持在临床实践中对未经治疗的和经验丰富的个体使用DOR.
科学领域:
- 传染性疾病 传染性疾病
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗逆转录病毒疗法 (ART) 对于控制人类免疫缺陷病毒 (HIV) 是至关重要的.
- 多拉维林 (DOR) 是一种用于HIV治疗方案的整合酶抑制剂.
- 评估基于DOR的ART的实际有效性对于临床决策很重要.
研究的目的:
- 评估基于多拉维林 (DOR) 的抗逆转录病毒疗法 (ART) 方案的抗病毒有效性和安全性.
- 在常规临床实践中,评估基于DOR的ART在未经治疗和经过治疗的艾滋病毒感染者 (PWH) 中.
主要方法:
- 在五个欧洲国家的16个地点进行了一项回顾性,非干预性研究.
- 该研究包括394名参与者 (63名未经治疗,331名经验丰富的治疗者) 开始或切换到含有DOR的ART.
- 主要终点是48周后的病毒学成功 (HIV RNA <50拷贝/毫升) 和失败 (HIV RNA ≥50拷贝/毫升).
主要成果:
- 在48周内,总体上90.6%的参与者获得了病毒学上的成功.
- 在未接受ART治疗的组中,成功率为87.3%,在经过治疗的组中为91.2%.
- 总体而言,病毒学失败发生在3.3%的患者中,只有1%的患者因不良事件而停止服用DOR.
结论:
- 基于多拉维林的疗法在艾滋病毒感染者的病毒抑制方面表现出很高的有效性.
- 这些疗法耐受性良好,不良事件发生率低,导致停止治疗.
- 这些发现支持在现实环境中在各种艾滋病毒患者群体中使用含有DOR的ART.
相关概念视频
Retrovirus Life Cycles
45.6K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.6K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Pharmacovigilance
769
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
769
Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Dosage Regimen: Fixed Dose
1.8K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.8K


